PhII EvalSafTolerabEfficPK&Immu AZD0901 Monothe&Combw/AntiCa Agen Partic w/AdvSolTuExpresClaudin18.2
Farshid Dayyani
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 6 of 6 Results
Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02
Namita Goyal
- OPEN TO ACCRUAL
Clinical Procedures to Support Research in ALS
Namita Goyal
- OPEN TO ACCRUAL
Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in ALS
Namita Goyal
- OPEN TO ACCRUAL
Parallel Ph III for High Risk Prostate Ca Evaluating De-Intensification & Intensification of Tx
David Hong
- OPEN TO ACCRUAL
COMPASSHER2 RD Ph III Trial of T-DM1 & Placebo Compared w/ T-DM1 & Tucatinib
Ritesh Parajuli
- OPEN TO ACCRUAL